Guardian Pharmacy Services Inc (GRDN) Financial Statements

GRDN Financial Data

EBITDA$102.14M

Revenue (TTM)$1.46B

Gross Profit (TTM)$304.68M

Gross Margin—

Operating Margin5.11%

ROE25.79%

ROA12.86%

Debt/Equity0.18

Current Ratio1.38

FCF$80.71M

FCF Yield3.48%

Piotroski F-Score—

Rev/Share (TTM)$22.99

50-Day MA$36.39

200-Day MA$30.45

Shares Outstanding0.06B

GRDN Computed Insights

FCF$80.71M

FCF Growth Rate36.47%

EPS Growth (CAGR)11.59%

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

GRDN Financial Statements & Data

Guardian Pharmacy Services Inc (GRDN) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Guardian Pharmacy Services Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $1.46B. Gross profit (TTM) is $304.68M. EBITDA is $102.14M. Earnings per share (EPS) is $0.78. The P/E ratio is 43.68. Market capitalization is $2.32B.

Free cash flow (FCF) is $80.71M. FCF growth rate is 36.47%. EPS growth CAGR is 11.59%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 4 years from FY22 to FY25. Net income history spans 4 years. Free cash flow and capital expenditure data spans 4 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Guardian Pharmacy Services Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.